Administration is responsible for the organizational support and fiscal oversight of all Case Comprehensive Cancer Center (Case CCC) activities based at Case Western Reserve University (CWRU) and its affiliated institutions. University Hospitals (UH) and Cleveland Clinic (CCF). As the center of operations for the Cancer Center, Administration is responsible for communicating regularly with members to disseminate opportunities for funding and scientific interactions, maintaining an integrated calendar of activities and providing a support service to implement retreats, meetings, and conferences, facilitating and managing multi-investigator grants, providing administrative support to the shared resources, and supporting post-doctoral training. A staff of 12 under the leadership of Anne Duli, MPA, Associate Director for Research Administration and Finance, directly manages over $15 million in annual cancer research support. Regular administrative meetings with UH and CCF administrators promote organizational integration for cancer research across the affiliated institutions. Topics for this group's meetings include flow of information across the consortium, developments and priorities for the Cancer Center, funding opportunities, grant oversight and reporting, clinical research topics, and improved processes for communication, funds transfer and reporting. Accomplishments for Administration include providing support for the reorganization and realignment of the scientific programs, for major initiatives such as strategic planning, developing a review process for tissue use, facilitating the applications for 7 new and renewal multidisciplinary projects, training grant renewals, over 10 applications for ARRA funding, and the successful recruitment of 8 new cancer research faculty, with 3 of them having primary appointments in the Cancer Center. Future plans include providing support for key scientific initiatives of the Cancer Center, the development of the Office of Cancer Health Disparities, partnering with the Clinical and Translational Research Collaborative to establish complementary resources, streamlining administrative inter-institutional transactions and strengthening internal management of financial information.
The Case Comprehensive Cancer Center is Northeast Ohio's only NCI designated comprehensive cancer center providing bench-to-bedside medical research involving partnerships between basic, clinical and population scientists to speed translation of laboratory discoveries into new prevention/intervention and cancer treatments.
|Zhao, S; Sedwick, D; Wang, Z (2015) Genetic alterations of protein tyrosine phosphatases in human cancers. Oncogene 34:3885-94|
|Dermawan, Josephine Kam Tai; Gurova, Katerina; Pink, John et al. (2014) Quinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-?B, and cell-cycle progression in non-small cell lung cancer. Mol Cancer Ther 13:2203-14|
|Brubaker, Douglas; Difeo, Analisa; Chen, Yanwen et al. (2014) Drug Intervention Response Predictions with PARADIGM (DIRPP) identifies drug resistant cancer cell lines and pathway mechanisms of resistance. Pac Symp Biocomput :125-35|
|Yori, Jennifer L; Lozada, Kristen L; Seachrist, Darcie D et al. (2014) Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression. Cancer Res 74:4762-71|
|Dabir, Snehal; Kluge, Amy; McColl, Karen et al. (2014) PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 status. Int J Cancer 134:1045-54|
|Zapanta Rinonos, Serendipity; Rai, Urvashi; Vereb, Sydney et al. (2014) Sequential logic of polarity determination during the haploid-to-diploid transition in Saccharomyces cerevisiae. Eukaryot Cell 13:1393-402|
|Sizemore, Gina M; Sizemore, Steven T; Seachrist, Darcie D et al. (2014) GABA(A) receptor pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular-regulated kinase 1/2 (ERK1/2). J Biol Chem 289:24102-13|
|Sossey-Alaoui, Khalid; Pluskota, Elzbieta; Davuluri, Gangarao et al. (2014) Kindlin-3 enhances breast cancer progression and metastasis by activating Twist-mediated angiogenesis. FASEB J 28:2260-71|
|Dotan, Efrat; Devarajan, Karthik; D'Silva, A James et al. (2014) Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer. Clin Colorectal Cancer 13:192-8|
|Arachiche, Amal; de la Fuente, María; Nieman, Marvin T (2014) Platelet specific promoters are insufficient to express protease activated receptor 1 (PAR1) transgene in mouse platelets. PLoS One 9:e97724|
Showing the most recent 10 out of 975 publications